We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PRM to Acquire Medical Manufacturing Technologies for $685M
Read MoreHide Full Article
Key Takeaways
PRM agreed to acquire MMT for about $685M in an all-cash deal expected to close by early 2026.
The purchase adds MMT's machinery and consumables business, which is set to earn $140M in revenues in 2025.
PRM plans to fund the deal with debt and cash, expecting net leverage of roughly 2.7x after closing.
Perimeter Solutions, Inc. (PRM - Free Report) announced a definitive agreement to acquire Medical Manufacturing Technologies LLC (“MMT”) from Arcline Investment Management for roughly $685 million. PRM will buy MMT under an all-cash deal, including specific tax benefits.
The transaction is expected to close by the first quarter of 2026 and will be funded through a new secured debt financing $500 million and $185 million of cash on hand.
MMT is a leading provider of highly engineered machinery and aftermarket consumables essential to manufacturing minimally invasive medical devices. This serves as an appropriate fit with PRM’s operating strategy.
MMT also has a strong history of organic and M&A driven growth. MMT generates most of its revenues from proprietary items, with about half derived from the aftermarket. For 2025, MMT is expected to log roughly $140 million in revenues and $50 million of adjusted EBITDA.
The deal complements Perimeter’s focus on businesses in secular growth markets with strong free cash flow, high returns on tangible capital and sustainable earnings power. Following the transaction, the company expects a net leverage ratio of about 2.7x net debt to combined adjusted EBITDA for the last 12 months ending Sept. 30, 2025. The transaction remains subject to regulatory approvals and other closing conditions.
PRM’s shares have gained 124.5% over the past year compared with the industry’s 8.5% decline.
Image Source: Zacks Investment Research
PRM’s Zacks Rank & Other Key Picks
PRM currently sports a Zacks Rank #1 (Strong Buy).
Some other top-ranked stocks in the Basic Materials space areKinross Gold Corporation (KGC - Free Report) , Fortuna Mining Corp. (FSM - Free Report) and Harmony Gold Mining Company Limited (HMY - Free Report) .
The Zacks Consensus Estimate for KGC’s current-year earnings is pegged at $1.67 per share, indicating a rise of 145.59%. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing it in one, with an average surprise of 17.37%. KGC’s shares have risen 194.4% over the past year.
The Zacks Consensus Estimate for FSM’s current fiscal-year earnings is pinned at 76 cents per share, indicating a 65.22% year-over-year increase. Its shares have surged 107.6% over the past year.
The Zacks Consensus Estimate for HMY’s 2026 earnings is pegged at $2.68 per share, indicating a 132.1% year-over-year increase. HMY’s shares have gained 121.2% over the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
PRM to Acquire Medical Manufacturing Technologies for $685M
Key Takeaways
Perimeter Solutions, Inc. (PRM - Free Report) announced a definitive agreement to acquire Medical Manufacturing Technologies LLC (“MMT”) from Arcline Investment Management for roughly $685 million. PRM will buy MMT under an all-cash deal, including specific tax benefits.
The transaction is expected to close by the first quarter of 2026 and will be funded through a new secured debt financing $500 million and $185 million of cash on hand.
MMT is a leading provider of highly engineered machinery and aftermarket consumables essential to manufacturing minimally invasive medical devices. This serves as an appropriate fit with PRM’s operating strategy.
MMT also has a strong history of organic and M&A driven growth. MMT generates most of its revenues from proprietary items, with about half derived from the aftermarket. For 2025, MMT is expected to log roughly $140 million in revenues and $50 million of adjusted EBITDA.
The deal complements Perimeter’s focus on businesses in secular growth markets with strong free cash flow, high returns on tangible capital and sustainable earnings power. Following the transaction, the company expects a net leverage ratio of about 2.7x net debt to combined adjusted EBITDA for the last 12 months ending Sept. 30, 2025. The transaction remains subject to regulatory approvals and other closing conditions.
PRM’s shares have gained 124.5% over the past year compared with the industry’s 8.5% decline.
Image Source: Zacks Investment Research
PRM’s Zacks Rank & Other Key Picks
PRM currently sports a Zacks Rank #1 (Strong Buy).
Some other top-ranked stocks in the Basic Materials space areKinross Gold Corporation (KGC - Free Report) , Fortuna Mining Corp. (FSM - Free Report) and Harmony Gold Mining Company Limited (HMY - Free Report) .
At present, KGC sports a Zacks Rank #1, while FSM and HMY carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for KGC’s current-year earnings is pegged at $1.67 per share, indicating a rise of 145.59%. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing it in one, with an average surprise of 17.37%. KGC’s shares have risen 194.4% over the past year.
The Zacks Consensus Estimate for FSM’s current fiscal-year earnings is pinned at 76 cents per share, indicating a 65.22% year-over-year increase. Its shares have surged 107.6% over the past year.
The Zacks Consensus Estimate for HMY’s 2026 earnings is pegged at $2.68 per share, indicating a 132.1% year-over-year increase. HMY’s shares have gained 121.2% over the past year.